Back to top

Research Daily

Zacks Equity Research

Top Research Reports for CVS Health, General Motors & Enterprise Products


Trades from $3

Tuesday, November 7, 2017

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including CVS Health (CVS), General Motors (GM) and Enterprise Products (EPD). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

CVS Health’s shares have outperformed the Zacks Drug Stores industry over the last six months losing -17.6% vs. a decline of -21.1%. CVS Health exited the third quarter on a solid note with both earnings and revenues remaining ahead of the expectations.

Slower revenue performance on poor Retail/LTC numbers as well as margin debacle resulted in such a dull bottom line performance by the company in the quarter. Nonetheless, year-over-year growth in the top line was due to strong Pharmacy Services segment that benefited from the upside in the Specialty Pharmacy.

The Zacks analyst is encouraged to note that, despite a soft bottom-line scenario, the company reiterated its earnings outlook for 2017 indicating chances of recovery ahead. The company’s on-going strong 2018 PBM selling season is another upside. Moreover, the Omnicare and Target Pharmacy buyouts are gradually driving enterprise value at CVS Health.

(You can read the full research report on CVS Health here >>>).

Shares of General Motors have outperformed the Zacks Domestic Automotive industry over the last six months, increasing +24% vs. +9%. General Motors delivered better-than-expected adjusted earnings per share in third-quarter 2017. Revenues also surpassed expectations.

In the United States, in October, the automaker reported 252,813 deliveries. During the month, pickup deliveries rose 9% year over year and crossover deliveries rose 12% year over year. The company aims to focus more on the development of electric vehicles and plans to roll out 20 electric or hydrogen fuel cell vehicles by 2023.

It is also emphasizing to strengthen its brands, increasing retail sales and maintaining operating discipline. However, frequent vehicle recalls, high inventory level of passenger cars and currency fluctuations are few concerns the company has been facing.

(You can read the full research report on General Motors here >>>).

Enterprise Products Partners' shares have gained +1.4 over the last year, even as the Zacks Oil Production Pipeline MLP industry declined by -7.7%. Enterprise Products has an extensive network of pipeline that spreads over almost 50,000 miles. The pipeline is connected to every major U.S. shale play and provides services to producers and users of commodities by transporting natural gas liquid (NGL), natural gas, crude oil and refined products.

The partnership has raised its cash distribution for 52nd successive quarters, reflecting stable fee-based cash flow from diversified midstream assets. It is expected that Enterprise Products Partners will maintain the trend as the partnership has a backlog of almost $9 billion fee-based growth projects.

However, the partnership’s escalating debt since 2012 reflects its weak balance sheet. The Zacks analyst is concerned about Enterprise Products’ rising operating costs.

(You can read the full research report on Enterprise Products Partners here >>>).

Other noteworthy reports we are featuring today Berkshire Hathaway (BRK.B), PetroChina (PTR) and Automatic Data Processing (ADP).

Zacks' Hidden Trades

While we share many recommendations and ideas with the public, certain moves are hidden from everyone but selected members of our portfolio services. Would you like to peek behind the curtain today and view them?

Starting now, for the next month, I invite you to follow all Zacks' private buys and sells in real time from value to momentum...from stocks under $10 to ETF to option movers...from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors.

Click here for Zacks' secret trade>>

Mark Vickery

Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Featured Reports

New Upgrades

New Downgrades